6.12
+0.017(+0.28%)
Currency In USD
| Previous Close | 6.1 |
| Open | 6.12 |
| Day High | 6.21 |
| Day Low | 6.02 |
| 52-Week High | 7.6 |
| 52-Week Low | 3.34 |
| Volume | 10,531 |
| Average Volume | 26,140 |
| Market Cap | 55.31M |
| PE | 29.14 |
| EPS | 0.21 |
| Moving Average 50 Days | 6.53 |
| Moving Average 200 Days | 5.35 |
| Change | 0.02 |
If you invested $1000 in ImmuCell Corporation (ICCC) 10 years ago, it would be worth $729.44 as of August 18, 2025 at a share price of $6.12. Whereas If you bought $1000 worth of ImmuCell Corporation (ICCC) shares 5 years ago, it would be worth $1,110.71 as of August 18, 2025 at a share price of $6.12.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ImmuCell Announces Bank Debt Refinancing
GlobeNewswire Inc.
Aug 12, 2025 8:05 PM GMT
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
GlobeNewswire Inc.
Aug 07, 2025 12:00 PM GMT
Conference Call Scheduled for Friday, August 15, 2025 at 9:00 AM ETPORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025
GlobeNewswire Inc.
Jul 09, 2025 12:00 PM GMT
PORTLAND, Maine, July 09, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve